Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
Status:
Completed
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The investigators are studying whether an anti-inflammatory intervention improves impaired
coronary endothelial function (CEF) in HIV+ people with no clinical coronary artery disease
(CAD).